The estimated Net Worth of Richard C Carlson is at least $264 mil dollars as of 2 February 2004. Richard Carlson owns over 9,500 units of Surmodics stock worth over $68,731 and over the last 21 years Richard sold SRDX stock worth over $195,225.
Richard has made over 1 trades of the Surmodics stock since 2004, according to the Form 4 filled with the SEC. Most recently Richard sold 9,500 units of SRDX stock worth $195,225 on 2 February 2004.
The largest trade Richard's ever made was selling 9,500 units of Surmodics stock on 2 February 2004 worth over $195,225. On average, Richard trades about 4,750 units every 0 days since 2004. As of 2 February 2004 Richard still owns at least 1,752 units of Surmodics stock.
You can see the complete history of Richard Carlson stock trades at the bottom of the page.
Richard's mailing address filed with the SEC is 9924, West 74th Street, Eden Prairie, Hennepin County, Minnesota, 55344, United States of America.
Over the last 21 years, insiders at Surmodics have traded over $26,204,565 worth of Surmodics stock and bought 19,725 units worth $436,251 . The most active insiders traders include Jeffrey C Smith, Gary R Maharaj y Value Lp Starboard Value Gp.... On average, Surmodics executives and independent directors trade stock every 34 days with the average trade being worth of $415,014. The most recent stock trade was executed by Joseph J. Stich on 21 August 2024, trading 21,285 units of SRDX stock currently worth $706,662.
surmodics partners with the world's leading and emerging medical device, diagnostic and life sciences companies to develop and commercialize innovative products designed to improve lives by enabling the detection and treatment of disease. following two recent acquisitions, the company is transforming its medical device business from being a provider of coating technologies, to offering whole-product solutions. throughout its transformation, surmodics’ mission remains: to improve the detection and treatment of disease by using our technology to provide solutions to difficult medical device and diagnostic challenges.
Surmodics executives and other stock owners filed with the SEC include: